Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

PR NewswireMarch 03, 2025

Tag: Callio Therapeutics , ADCs , Frazier Life Sciences

PharmaSources Customer Service